False Positive Findings of [(18)F]PSMA-1007 PET/CT in Patients After Radical Prostatectomy with Undetectable Serum PSA Levels

BACKGROUND: PET-CT using prostate-specific membrane antigen (PSMA)-targeting radiopharmaceuticals labeled with (68)Ga or (18)F has emerged as the most sensitive staging tool in prostate cancer (PC). Nonetheless, the occurrence of false positive (FP) findings presents a major concern of this approach...

Descripción completa

Detalles Bibliográficos
Autores principales: Orevi, Marina, Ben-Haim, Simona, Abourbeh, Galith, Chicheportiche, Alexandre, Mishani, Eyal, Yutkin, Vladimir, Gofrit, Ofer N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Surgery
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9263625/
https://www.ncbi.nlm.nih.gov/pubmed/35813044
http://dx.doi.org/10.3389/fsurg.2022.943760

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9263625/
https://www.ncbi.nlm.nih.gov/pubmed/35813044
http://dx.doi.org/10.3389/fsurg.2022.943760

Ejemplares similares